Sign in

CIK 0001367083

  • Non-accelerated filer
  • Smaller reporting company

Sonoma Pharmaceuticals, Inc.

Sign in to watch
Ticker
SNOA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
680423298
Phone
+1 800-759-9305
Business address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
Former names
Oculus Innovative Sciences, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award Director acquired 1,781 shares (grant or award)
  9. 4 Grant or award Director acquired 1,538 shares (grant or award)
  10. 4 Grant or award Director acquired 1,052 shares (grant or award)
  11. 4 Open-market buy Chief Financial Officer bought 2,400 shares at an average $4.06 ($9,756)
  12. 4 Open-market buy Chief Financial Officer bought 2,400 shares at an average $3.97 ($9,516)
  13. 4 Open-market buy Chief Executive Officer bought 2,473 shares at $3.99 ($9,867)
  14. 4 Grant or award Director acquired 1,424 shares (grant or award)
  15. 4 Grant or award Director acquired 1,157 shares (grant or award)
  16. 4 Grant or award Director acquired 1,691 shares (grant or award)
  17. 4 Grant or award Director acquired 1,958 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 17,211 shares (grant or award)
  19. 4 Grant or award Director acquired 17,211 shares (grant or award)
  20. 4 Grant or award Director acquired 17,211 shares (grant or award)

Page 4 of 16 · 317 filings